| | 1123211-65-3 Basic information More.. |
| Product Name: | ClindaMycin PalMiitate Sulfoxide | | Synonyms: | ClindaMycin PalMiitate Sulfoxide;Clindamycin Palmitate Sulfoxide;Clindamycin Palmitate Sulfoxide HCl;[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfinyloxan-3-yl] hexadecanoate;L-threo-α-D-galacto-Octopyranose, 7-chloro-1,6,7,8-tetradeoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-, 2-hexadecanoate;Sulfoxide Clindamycin Palmitate;Revefenacin Impurity 65;(2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylsulfinyl)tetrahydro-2H-pyran-3-yl palmitate | | CAS: | 1123211-65-3 | | MF: | C34H63ClN2O7S | | MW: | 679.4 | | EINECS: | | | Mol File: | 1123211-65-3.mol |  |
Use
Clindamycin Palmiitate Sulfoxide is an impurity in the synthesis of Clindamycin Palmitate Hydrochloride (C580035), a semi-synthetic antibiotic with high bioavailability. Clindamycin Palmitate is an antibacterial.
|
|
1123211-65-3
Recommend Suppliers |
|